MiR-149 was down-regulated in the livers of NAFLD mice, and administration of miRNA-149-mimic to these mice resulted in elevation of lipid metabolism proteins SCD-1, PPARα and ABCA1 and reduced fatty tissue. This evidence concerns the gene SCD and metabolic dysfunction-associated steatotic liver disease.